These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 32598755)

  • 1. [Glucocorticosteroids for people with alcoholic hepatitis (Cochrane review)].
    Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
    Ter Arkh; 2019 Aug; 91(8):52-66. PubMed ID: 32598755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticosteroids for people with alcoholic hepatitis.
    Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD001511. PubMed ID: 29096421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticosteroids for people with alcoholic hepatitis.
    Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001511. PubMed ID: 30964545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.
    Fairfield C; Penninga L; Powell J; Harrison EM; Wigmore SJ
    Cochrane Database Syst Rev; 2015 Dec; (12):CD007606. PubMed ID: 26666504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline for alcoholic hepatitis.
    Whitfield K; Rambaldi A; Wetterslev J; Gluud C
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD007339. PubMed ID: 19821406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review: glucocorticosteroids for alcoholic hepatitis--a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials.
    Rambaldi A; Saconato HH; Christensen E; Thorlund K; Wetterslev J; Gluud C
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1167-78. PubMed ID: 18363896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
    Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D supplementation for prevention of cancer in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Krstic G; Wetterslev J; Gluud C
    Cochrane Database Syst Rev; 2014 Jun; (6):CD007469. PubMed ID: 24953955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Sep; (9):CD001939. PubMed ID: 26377410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticosteroids for viral hepatitis C.
    Brok J; Mellerup MT; Krogsgaard K; Gluud C
    Cochrane Database Syst Rev; 2004; 2004(2):CD002904. PubMed ID: 15106184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis.
    Parker R; Armstrong MJ; Corbett C; Rowe IA; Houlihan DD
    Aliment Pharmacol Ther; 2013 May; 37(9):845-54. PubMed ID: 23489011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticosteroids for sepsis in children. A protocol for a systematic review.
    Korang SK; Gluud C; Jakobsen JC
    Acta Anaesthesiol Scand; 2019 Jul; 63(6):819-826. PubMed ID: 30919946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the Editor: Glucocorticosteroids for Alcohol-Associated Hepatitis.
    Varganova DL; Pavlov CS; Casazza G; Nikolova D; Gluud C
    Hepatology; 2020 Apr; 71(4):1524. PubMed ID: 31660631
    [No Abstract]   [Full Text] [Related]  

  • 16. Past, Present, and Future Therapies for Alcohol-associated Hepatitis.
    Condon S; Jophlin LL
    Clin Ther; 2023 Dec; 45(12):1171-1176. PubMed ID: 37980219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective clinical trials and novel therapies in the medical management of severe alcohol-associated hepatitis.
    Pimienta M; Tien C; Terrault NA
    Clin Liver Dis (Hoboken); 2022 Dec; 20(6):202-208. PubMed ID: 36523864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis.
    Vergis N; Patel V; Bogdanowicz K; Czyzewska-Khan J; Fiorentino F; Day E; Cross M; Foster N; Lord E; Goldin R; Forrest E; Thursz M
    Trials; 2021 Nov; 22(1):792. PubMed ID: 34763711
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.